ArticleThoracic cancer2018

Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.

Zui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.